We can't find the internet
Attempting to reconnect
Something went wrong!
Hang in there while we get back on track
Methods to alleviate the inhibition of sludge anaerobic digestion by emerging contaminants: a review
Summary
This review examines emerging contaminants in sewage sludge, including pharmaceuticals and microplastics, that inhibit the anaerobic digestion process used in wastewater treatment. Researchers found that pharmaceuticals were detected in about 50% of sludge samples, and that remediation methods such as ozonation, electrooxidation, and bioaugmentation can help alleviate inhibition, though liquid digestates still contain concerning pollutant levels.
Abstract The rising occurrence of emerging contaminants in sludges both inhibits the anaerobic digestion of sludges and induces health issues when sludges are recycled in agriculture, calling for methods to remove contaminants. Here we review emerging pollutants in wastewater treatment plants, before and after anaerobic digestion. We present their inhibitory effects and remediation methods to alleviate inhibition. Pharmaceuticals have been detected in about 50% of the sludge samples. Sewage sludge contaminants include 19% of diuretics, 16–21% of lipid-modifying agents, hydrochlorothiazide, diclofenac, furosemide, clarithromycin, atorvastatin, and carbamazepine. Levels of antibiotics, azithromycin, ciprofloxacin, and estrone range from 500 to 600 ng/g in sludges from wastewater treatment plants. Remediation methods comprise electrooxidation, ultrasonication, thermal hydrolysis, ozonation, and bioaugmentation. Fermenting the sludges with acidogenic bacteria reduces the level of emerging pollutants in the supernatant. Nonetheless, liquid digestates still contains emerging pollutants such as sunscreen octocrylene at 147 ug/L and acetaminophen at 58.6 ug/L. As a result, pretreatment of sludge containing emerging pollutants is required.
Sign in to start a discussion.